ON-DEMAND WEBINAR
How to Approach the Most Critical Measurement in TMVR Planning
By Dr. Dee Dee Wang, M.D., FACC, FASE - Director, Center for Structural Heart Disease and Medical Director, 3D Printing at the Henry Ford Innovations Institute
Transcatheter mitral valve replacement (TMVR) is a treatment that requires detailed pre-procedural planning. 3D models derived from CT scans offer the ability to assess patient anatomy and plan for a procedure in a more intuitive, accurate, and consistent way.
In this webinar Dr. Wang from the Henry Ford Institute shares how she approaches the most critical measurement in TMVR planning: the neo-LVOT.
She explains how using CT-derived models for 3D planning provides unprecedented insight into the neo-LVOT and clinical confidence for the interventional teams.
.jpg)
In this webinar, you will learn:
-
To identify the mechanisms of LVOT obstruction
-
The importance of 3D modeling to correctly identify the neo-LVOT with different implant types/designs
-
To estimate patients risk based on neo-LVOT measurements
Materialise medical device software may not be available in all markets because product availability is subject to the regulatory and/ or medical practices in individual markets. In countries where no regulatory registration is obtained of Mimics and/or 3-matic Medical, a research version is available. Please contact your Materialise representative if you have questions about the availability of Materialise medical device software in your area.
L-101649-01
Dee Dee Wang,
MD, FACC, FASE, FSCCT
Henry Ford Health System, USA
Dr. Wang is a Level 3 Cocats trained in echocardiography (with 3D TEE), nuclear, and cardiac CTA; and a Level 2 Cocats trained in cardiac MRI and cardiac PET. She specializes in interventional imaging in structural heart interventions including transcatheter mitral valve replacement therapies, tricuspid interventions, mitral e-clip, complex TAVRs/adult-congenital cases, LAA interventions, and ASD/PFO closures. Dr. Wang’s research interests are focused on advancing patient safety and procedural outcomes utilizing 3D+4D imaging and 3D printing for high-risk structural heart interventions.